Interleukin-2 – induced vascular leak syndrome: clinically relevant in vitro recapitulation with a patient-derived lung-on-chip
G. Raggi (Bern, Switzerland), N. Roldan (Bern, Switzerland), V. Micallef (Basel, Switzerland), A. Rapet (Bern, Switzerland), L. De Maddalena (Bern, Switzerland), T. Imler (Bern, Switzerland), L. Froment (Bern, Switzerland), T. Marti (Bern, Switzerland), R. Schmid (Bern, Switzerland), E. Breous-Nystrom (Basel, Switzerland), A. Roth (Basel, Switzerland), L. Cabon (Basel, Switzerland), N. Hobi (Bern, Switzerland)
Source: Virtual Congress 2020 – Lung epithelial development and repair in three-dimensions
Disease area: -
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Raggi (Bern, Switzerland), N. Roldan (Bern, Switzerland), V. Micallef (Basel, Switzerland), A. Rapet (Bern, Switzerland), L. De Maddalena (Bern, Switzerland), T. Imler (Bern, Switzerland), L. Froment (Bern, Switzerland), T. Marti (Bern, Switzerland), R. Schmid (Bern, Switzerland), E. Breous-Nystrom (Basel, Switzerland), A. Roth (Basel, Switzerland), L. Cabon (Basel, Switzerland), N. Hobi (Bern, Switzerland). Interleukin-2 – induced vascular leak syndrome: clinically relevant in vitro recapitulation with a patient-derived lung-on-chip. 4326
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: